-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Zevra Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q2 2024.
- Zevra Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $23.1M, a 64.6% increase year-over-year.
- Zevra Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $92.5M, a 82.2% increase year-over-year.
- Zevra Therapeutics, Inc. annual Costs and Expenses for 2023 was $77.1M, a 46.2% increase from 2022.
- Zevra Therapeutics, Inc. annual Costs and Expenses for 2022 was $52.7M, a 152% increase from 2021.
- Zevra Therapeutics, Inc. annual Costs and Expenses for 2021 was $20.9M, a 10.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)